Patients suffering from DM experience more severe COVID-19 symptoms than non-diabetic patients [4,5,6], because DM is a risk factor for upregulated angiotensin-converting enzyme-2 (ACE2) gene expression due to hyperglycemic conditions [7,8]. This evidence concerns the gene ACE2 and COVID-19.